Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer

Abstract Background Axillary disease extent according to baseline [18F]fluorodeoxyglucose PET/CT combined with pathological axillary treatment response has been proposed to guide de-escalation of axillary treatment for clinically node-positive breast cancer patients treated with neoadjuvant systemic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of surgery 2024-09, Vol.111 (9)
Hauptverfasser:	van Amstel, Florien J G, de Mooij, Cornelis M, Simons, Janine M, Mitea, Cristina, van Diest, Paul J, Nelemans, Patty J, van der Pol, Carmen C, Luiten, Ernest J T, Koppert, Linetta B, Smidt, Marjolein L, van Nijnatten, Thiemo J A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Axilla Breast Neoplasms - diagnostic imaging Breast Neoplasms - pathology Breast Neoplasms - therapy Female Fluorodeoxyglucose F18 Humans Lymphatic Metastasis - diagnostic imaging Middle Aged Neoadjuvant Therapy Positron Emission Tomography Computed Tomography - methods Prospective Studies Radiopharmaceuticals Sentinel Lymph Node Biopsy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!